ag 3-5 has been researched along with urb 597 in 1 studies
| Studies (ag 3-5) | Trials (ag 3-5) | Recent Studies (post-2010) (ag 3-5) | Studies (urb 597) | Trials (urb 597) | Recent Studies (post-2010) (urb 597) |
|---|---|---|---|---|---|
| 126 | 0 | 66 | 455 | 0 | 297 |
| Protein | Taxonomy | ag 3-5 (IC50) | urb 597 (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 0.213 | |
| Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.0046 | |
| Coagulation factor XIII A chain | Homo sapiens (human) | 0.0277 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 1.1 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.0365 | |
| Fatty-acid amide hydrolase 2 | Homo sapiens (human) | 0.005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
1 review(s) available for ag 3-5 and urb 597
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |